Akero Therapeutics, Inc.
(NASDAQ : AKRO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.68%145.650.7%$932.14m
PFEPfizer Inc. 0.84%36.060.9%$892.16m
MRKMerck & Co., Inc. -0.24%82.950.7%$692.55m
ABBVAbbVie, Inc. 0.35%86.211.9%$677.02m
BMYBristol-Myers Squibb Co. 2.15%59.501.0%$637.89m
LLYEli Lilly & Co. 0.97%150.261.1%$561.78m
AZNAstraZeneca Plc 2.47%55.511.2%$257.73m
NVSNovartis AG 0.96%87.130.2%$163.92m
GSKGlaxoSmithKline Plc 1.12%37.800.2%$109.18m
PRNBPrincipia Biopharma, Inc. 0.10%100.050.0%$86.76m
NVONovo Nordisk A/S 1.13%69.040.1%$57.64m
RGENRepligen Corp. 3.12%144.307.1%$49.54m
SNYSanofi -0.02%50.780.2%$49.00m
RPRXRoyalty Pharma Plc -0.40%40.070.2%$47.01m
OPKOPKO Health, Inc. 4.89%3.2211.2%$43.56m

Company Profile

Akero Therapeutics, Inc. operates as a biotechnology company. The firm specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. The company was founded by Jonathan Young and Timothy Rolph on January 24, 2017 and is headquartered in South San Francisco, CA.